Related Experiment Videos
[Steroid-induced osteoporosis: pathogenesis and therapeutic consequences]
A Kirchgatterer1, G Aschl, P Knoflach
1Internen Abteilung mit Gastroenterologie und Rheumatologie des a. ö. Krankenhauses der Barmherzigen Schwestern vom Hl. Kreuz, Wels.
Acta Medica Austriaca
|May 17, 2000
Summary
Long-term steroid treatment can cause osteoporosis, a serious complication. Early risk assessment and interventions like calcium, vitamin D, and bisphosphonates are crucial for prevention.
Area of Science:
- Endocrinology and Bone Metabolism
- Pharmacology and Therapeutics
Context:
- Chronic inflammatory diseases often necessitate long-term corticosteroid therapy.
- A significant percentage of patients on steroids develop osteoporosis, a major complication.
Purpose:
- To highlight steroid-induced osteoporosis as a critical secondary cause of bone loss.
- To emphasize the complex pathogenesis involving hormonal changes, calcium balance, and reduced osteoblast activity.
Summary:
- Steroids decrease bone mineral density and increase fracture risk by reducing osteoblast activity and affecting hormone levels.
- Risk factors include steroid dosage, lifestyle, menopausal status, low bone density, and prior fractures.
Impact:
- Promotes proactive patient evaluation and risk stratification for steroid-induced osteoporosis.
- Recommends preventive strategies including calcium, vitamin D, hormone therapy, and bisphosphonates based on individual risk.